Previous 10 | Next 10 |
2024-03-28 12:39:10 ET Read the full article on Seeking Alpha For further details see: NXST, GNTX, and COKE among the best mid-cap technical ideas - Roth MKM
2024-03-26 11:45:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Nvidia (NASDAQ: NVDA ) is massive. It is the third-largest company by market capitalization. In a little more than one year, the artificial intelligence ( AI ) chipmaker gre...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced that more than three million ICLs have been sold globally. 1 This press re...
2024-03-13 10:43:07 ET Summary STAAR Surgical Company's share price has experienced significant volatility, dropping over 60% in less than 9 months between 2022 and 2023. The company's 2023 earnings showed a 13% increase in net sales, however, with strong performance in China offs...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmatism and presbyopia, today announced the appointment of Arthur Butcher, Executive Vice President and Group President, MedSurg and A...
2024-03-11 09:30:03 ET Barclays analyst issues UNDERPERFORM recommendation for STAA on March 11, 2024 08:16AM ET. The previous analyst recommendation was Underperform. STAA was trading at $35.86 at issue of the analyst recommendation. The overall analyst consensus : BUY....
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced that management will participate in meetings with investors at the following confe...
Generates Double-Digit Sales Growth and Continuing Profitability ICL Sales Up 22% in Fourth Quarter and 18% in Fiscal 2023 Affirms Sales Outlook for Fiscal 2024 STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Imp...
SUIC Worldwide Holdings Ltd (SUIC) is expected to report for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 uniQure N.V. (QURE) is expected to report $-1.54 for Q4 2023 Albany International Corporation (AIN) is expected to report $0.84 for Q4 2023 I...
2024-02-25 17:35:04 ET Major earnings expected after the bell on Monday include: Zoom Video Communications ( ZM ) Unity Software ( U ) ONEOK ( OKE ) Innovative Industrial Properties ( IIPR ) Workday ( WDAY ) Read the full article on Seeking ...
News, Short Squeeze, Breakout and More Instantly...
STAAR Surgical Company Company Name:
STAA Stock Symbol:
NASDAQ Market:
STAAR Surgical Company Website:
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, invites investors and the general public to listen to a webcast fireside chat with Patrick F. Will...
2024-05-24 07:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
EVO ICL™ Continues to Outpace Refractive Industry Growth Record Quarterly U.S. Sales and Multiple Strategic Agreements Secured Reiterates Fiscal 2024 Net Sales Outlook and Increases Adjusted EBITDA STAAR Surgical Company (NASDAQ: K), a leading developer, manufactu...